Cutaneous toxicities are common in melanoma patients undergoing treatment with targeted or immune therapy, and dermatological assessment is advised in the initial stage of treatment, in particular if there is a background of underlying skin conditions.
In this presentation, Dermatologist A/Prof Guitera outlines how to identify and manage the skin side effects that can be observed with these treatments, such as photosensitivity, cutaneous SCC, actinic keratoses, Grover’s disease, dermatitis, lichenoid dermatitis, pruritus and side effect of steroids treatment.
A/Prof Pascale Guitera
Dermatologist, Melanoma Institute Australia | Director, Sydney Melanoma
Diagnostic Centre, Royal Prince Alfred Hospital